Showing results (181-190 of 242) with videos related to
Sort By:
Pageof 25
Brain Sciences|June 15, 2013
Neurochemical analysis of primary motor cortex in chronic low back painNeena K Sharma, William M Brooks, Anda E Popescu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignanciesS A Giralt, C F LeMaistre, H M Vriesendorp, et al.Pediatric Research|July 1, 2016
Prenatal DHA supplementation and infant attentionJohn Colombo, Kathleen M Gustafson, Byron J Gajewski, et al.Bone Marrow Transplantation|April 21, 2001
Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survivalK van Besien, A Rodriguez, S Tomany, et al.Journal of Neurotrauma|July 16, 2020
Sliding Scoring of the Glasgow Outcome Scale-Extended as Primary Outcome in Traumatic Brain Injury TrialsSharon D Yeatts, Reneé H Martin, William Meurer, et al.Contemporary Clinical Trials Communications|October 28, 2025
Protocol for the rural engagement in TelemedTeam for options in obesity treatment solutions (RE-TOOL): Cluster randomized trial investigating team-based telemedicine in rural primary careAlexandra R Brown, Edward F Ellerbeck, Debra K Sullivan, et al.Contemporary Clinical Trials Communications|June 9, 2020
Improving the efficiency of clinical trials by standardizing processes for Investigator Initiated TrialsDinesh Pal Mudaranthakam, Milind A Phadnis, Ron Krebill, et al.Leukemia & Lymphoma|December 28, 1999
Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemiaS Sacchi, H M Kantarjian, E J Freireich, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemiaH M Kantarjian, M Talpaz, T L Smith, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2001
Adenovirus infections in adult recipients of blood and marrow transplantsA M La Rosa, R E Champlin, N Mirza, et al.Pageof 25